ArticleFrontiers in cellular and infection microbiology2026
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: We integrated clinical data, antimicrobial susceptibility testing, and whole-genome sequencing (WGS) for four Results: A 53-year-old uncontrolled type 2 diabetes patient developed septic shock with pronounced inflammatory response (PCT 13.32 ng/mL, CRP 364.85 mg/L). WGS confirmed 0 core-genome SNP differences between blood (20250131) and wound (20250137) isolates, validating clonal transmission from the foot ulcer. All four institutional isolates were ST2250, sharing 12 core antimicrobial resistance-associated (AMR) genes. Global analysis identified the dominance of ST2250 (55.9% of 370 genomes), with 101 out of 147 (68.7%) observed between 2015 and 2019 among the dated genomes (68.7% of 268 genomes with a known collection year). ST2250 exhibited unique AMR signatures: highest Conclusions: This study provides genetic validation of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.